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Abstract
One enzyme which catalyzes the last step of the formation of
the hormone retinoic acid from vitamin A (retinol) is retinal
dehydrogenase type II (RalDH2). RalDH2, expressed in the
Escherichia coli BL21(DE3) strain, was puri®ed and crystal-
lized using ammonium sulfate as a precipitant. These crystals
belong to the space group P212121 (a = 108, b = 150, c = 168 AÊ ,
 =  =  = 90).
1. Introduction
In vivo retinoic acid is produced from retinol in a two-step
process which requires the action of binding proteins and
enzymes: retinol is oxidized to retinal which is in turn oxidized
to retinoic acid. Cellular retinol binding proteins (CRBP) and
cellular retinoic acid binding proteins (CRABP) may protect
the retinoids from inappropriate chemical modi®cation, and
may protect the cell from the amphipathic properties of the
retinoid or the uncontrolled signaling effects of unchaperoned
hormone (Napoli, 1996). Liganded binding proteins act as
substrates for the enzymes that metabolize retinoids (Napoli et
al., 1995; Boerman & Napoli, 1995b; Ong et al., 1994). For
example, retinol bound to CRBP acts as a substrate for retinol
dehydrogenases which convert retinol to retinal (Napoli et al.,
1995; Boerman & Napoli, 1995a,b). It has been proposed that
retinal bound to CRBP may act as the substrate for retinal
dehydrogenase, which catalyzes the production of retinoic acid
(Napoli, 1996). Retinoic acid then binds to CRABP for further
metabolism by enzymes such as the P450's (Boylan & Gudas,
1991), or is sequestered for nuclear localization and activation
of the transcription factors RAR and RXR (Giguere, 1994). It
has been proposed that retinoic acid may also be exported,
affecting cells that cannot synthesize the hormone (Napoli,
1996).
RalDH2 belongs to the superfamily of aldehyde dehy-
drogenases which is subdivided into three classes. Classes I and
II are comprised of tetrameric isozymes (subunit ' 55 kDa).
The isozymes of class I are cytosolic while those of class II are
mitochondrial (Lindahl & Hempel, 1991). Class III aldehyde
dehydrogenases are smaller dimeric and primarily tumor
speci®c, inducible or found in the endoplasmic reticulum
(Hempel & Lindahl, 1989). All three classes require the
cofactor nicotinamide adenine dinucleotide. Classes I and II
share approximately 70% sequence identity. However, within a
class, these enzymes are approximately 95% identical (Hempel
& Lindahl, 1989). X-ray crystallographic structures of a class II
aldehyde dehydrogenase and of a class III aldehyde dehy-
drogenase have been recently reported (Steinmetz et al., 1997;
Liu et al., 1997).
RalDH2 is a homotetramer of 55 kDa monomers which is
approximately 70% identical to either the class I or class II
enzymes (Zhao et al., 1996; Wang et al., 1996). RalDH2 cata-
lyzes the formation of retinoic acid in mouse embryonic eye
and trunk/spinal cord (Zhao et al., 1996), and rat testis (Wang
et al., 1996). Zhao and colleagues have suggested that RalDH2
localization and the subsequent production of retinoic acid by
the enzyme allows for nested gene activation and pattern
formation in the early embryo (Zhao et al., 1996).
Based on the recently reported structures of the class II and
class III enzymes, one would assume that a crystal structure of
RalDH2 will display an = catalytic domain, a Rossmann fold
nucleotide-binding domain, and a -sheet tetramerization
domain (Steinmetz et al., 1997; Liu et al., 1997). In order to
understand better the mechanism of retinal speci®city of this
aldehyde dehydrogenase, we have initiated crystal structure
determination studies. These and future studies may also
elucidate the possible interaction domains of RalDH2 for
other proteins in the enzymatic pathway, such as the cellular
retinoid binding proteins.
2. Materials and methods
2.1. Expression and puri®cation of rat retinal dehydrogenase
type II
The plasmid containing the coding sequence of RalDH2
with an N-terminal polyhistidine tag was transformed into
BL21(DE3) E. coli by the CaCl2 method. Bacteria were grown
in Terri®c Broth (Difco) at 310 K until the absorbance at A600
reached 0.6±0.8. The temperature was lowered to 291 K and
the E. coli were induced with 0.4 mM isopropyl -d-thio-
galactopyranoside for 24 h.
2.2. Puri®cation of RalDH2
E. coli were pelleted (5000g, 277 K, 15 min), resuspended in
lysis buffer (20 mM imidazole acetate pH 8.0, 2 mM -
mercaptoethanol) with 2 mM PMSF, 20 mg mlÿ1 pepstatin,
20 mg mlÿ1 leupeptin and 200 U mlÿ1 DNase I, and lysed in a
French press. The lysate was centrifuged (10 000g, 277 K,
30 min), and the supernatant was loaded onto a 2 ml Ni-NTA
agarose (Qiagen) batch column and incubated for 1 h. The
sample was allowed to ¯ow through and the column was
washed with lysis buffer until an A280 less than 0.1 was
obtained. The column was washed with wash buffer [20 mM
imidazole acetate pH 8.0, 250 mM NaCl, 2 mM -mercap-
toethanol, 1 mM -octylglucoside, 10%(v/v) glycerol] until the
A280 fell below 0.1. RalDH2 was eluted with a step gradient
[20±220 mM imidazole acetate pH 8.0, 250±300 mM NaCl,
2 mM -mercaptoethanol, 1 mM -octylglucoside, 10%(v/v)
glycerol; 20 mM imidazole and 5 mM NaCl each step]. The
fractions containing RalDH2 were concentrated under
nitrogen in an Amicon stirred cell with a YM30 membrane and
subsequently applied to an S300-sepharose column. The S300
column was eluted with 20 mM Hepes pH 8.5, 150 mM KCl,
1 mM EDTA, 2 mM -mercaptoethanol. All buffers were
thoroughly degassed with He sparging immediately prior to
use.
An activity assay was conducted in 1 ml of 20 mM Hepes
pH 8.5, 150 mM KCl, 1 mM EDTA, 1 mM dithiothreitol, 2 mM
NAD by monitoring the synthesis of NADH (increasing
absorbance at 340 nm) at 298 K for 2 min after a 1 min delay.
Retinal was not used as a substrate because its A340 completely
conceals the absorbance of the synthesized NADH. The
reaction was initiated by addition of the substrate analogs
octanal (5 mM) or decanal (3 mM) in ethanol (Wang et al.,
1996).
Thiol group determination was carried out as previously
reported (Ellman, 1959).
2.3. Crystallization
Crystallization screens were initially carried out using the
Hampton Research Crystal Screens 1 and 2 and the hanging-
drop method. Drops were 2 ml of the protein solution
(10 mg mlÿ1) and an equal volume of the well solution. Screens
were performed in the absence and presence of NAD, retinal
and/or 3-acetylpyridine adenine dinucleotide, a non-hydro-
lyzable NAD anaolgue. A-form crystals were grown by the
sitting-drop method using a reservoir solution of 100 mM
imidazole acetate pH 6.5, 0.80±1.0 M NaOOCH3, 0.6 M NaCl,
15±35 mM cysteine, all thoroughly degassed with He sparging
immediately prior to use. The trays were set up on ice with
chilled buffers and then placed in a 298 K incubator. Drops of
10 ml of protein solution (5 mg mlÿ1 with 2 mM NAD) were
mixed with an equal volume of the reservoir solution. B-form
crystals were grown by the sitting-drop method using a reser-
voir solution of 100 mM MES pH 6.5, 1.6±1.8 M (NH4)2SO4,
5% dioxane, and 1±6% ethylene glycol, all thoroughly
degassed with He sparging immediately prior to use. The trays
were set up on ice with chilled buffers and then placed in a
298 K incubator. Drops of 10 ml of protein solution (5 mg mlÿ1
with 2 mM NAD, 2 mM -ionone) were mixed with an equal
volume of the reservoir solution.
2.4. Diffraction measurements
Diffraction data of the A crystals were collected at 123 K on
an R-axis II image-plate system mounted on a Rigaku RU-200
rotating anode. The exposure time per frame (0.5) was 20 min
with a crystal-to-detector distance of 165 mm. Diffraction data
of the B crystals were collected at 123 K at the Cornell High
Energy Synchrotron Source at beamline F2. Oscillation frames
of 0.7 and 20 s were collected at  = 1.07 AÊ with a crystal-to-
detector distance of 80 mm. A second data set of crystal B
diffraction data was collected at 123 K on an R-axis II image-
plate system mounted on a Rigaku RU-200 rotating anode.
The exposure time per frame (0.7) was 45 min with a crystal-
to-detector distance of 165 mm. All data were processed using
DENZO (Otwinoswki, 1993; Minor, 1993).
2.5. Diffraction analysis
Pseudo precession photographs were generated using
Precess (Furey & Swaminthan, 1998). Self-rotation functions
were calculated using X-PLOR (BruÈ nger, 1992).
3. Results and discussion
RalDH2 which was eluted from the Ni-NTA agarose column
was used to perform crystallization screens and was found to
crystallize in the A conditions, but the crystals were of poor
quality (see Fig. 1a). Further puri®cation was required for
improved crystal quality. An S300 column eliminated
contaminating bands noted on silver-stained polyacrylamide
gel electrophoresis (PAGE) and resulted in a signi®cant
increase in the speci®c activity, as determined by the produc-
tion of NADH in the presence of the substrate analog octanal.
However, the increased purity was achieved at considerable
cost to the yield of the preparation: approximately 20 mg lÿ1
culture after the Ni-NTA step to 5 mg lÿ1 culture after the
S300 step.
Subsequently, it was noted that protein oxidation appeared
to be another cause of poor crystal quality. Crystals grown
without sparging the buffers with He did not crush easily as
protein crystals should. In fact, these crystals could be dropped
into deionized water and would not dissolve! This observation
could be the result of free-thiol crosslinks as RalDH2 has at
least three free thiols per monomer as determined by quanti-
tation with 5,50 dithiobis(2-nitrobenzoic acid). When the
Fig. 1. (a) Type A crystal grown after the ®rst step of the puri®cation
(Ni-NTA agarose column). (b) On bottom, a type A crystal grown
after complete puri®cation. On top, a cysteine crystal that grew
simultaneously. (c) Type B crystals.
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buffers are thoroughly degassed, the crystals grow to a suitable
size for diffraction experiments and crush nicely as one would
expect. Interestingly, protein not run on the S300 can grow
crystals without cysteine as an additive. However, RalDH2 run
over the S300 requires cysteine in the precipitating solution.
The best RalDH2 A-form crystals are those that have under-
gone the complete puri®cation procedure and are grown in the
presence of NAD. Initial A crystals could be seen after 3 d and
the crystals grew to 0.1  0.1 0.25 mm in 1±2 weeks (see Fig.
1b). It should be noted that cysteine crystals grow simulta-
neously in the drop. These crystals can be differentiated from
RalDH2 crystals by their hexagonal morphology and because
they also grow in the absence of protein (see Fig. 1b).
A single A-form RalDH2 crystal was used to collect a data
set to 2.7 AÊ (92.2% complete, Rmerge = 8.8%). The data were
processed in the space group P2 with cell dimensions of a = 85,
b = 150, c = 110 AÊ ,  = 110. If a tetramer comprises the
asymmetric unit (V = 660 000 AÊ 3), the Vm value is
2.97 AÊ 3 Daÿ1 and the probable solvent content is 59%
(Matthews, 1968). However, when examining data from A-
form crystals and the ®t generated by DENZO, one notes at
least 100 extra spots per frame. Also, these crystals freeze very
inconsistently and produce diffraction data with variable, and
mostly unusable, mosaicity and Rmerge values. There was
considerable streaking of the spots along the a axis, frequently
causing a doubling of this axis length during processing (see
Fig. 2a). Many cryo-protectants were tried including sucrose,
glucose, glycerol, ethylene glycol, PEG 400, and combinations
of these.
In an attempt to ®nd crystals which could be reproducibly
frozen to yield high-quality X-ray data, a new crystallization
screen was performed with the now well puri®ed protein. The
best crystals were grown with ammonium sulfate and dioxane
as precipitants (the B conditions) and in the presence of NAD
and -ionone. It was observed that nucleation was reduced in
the presence of ethylene glycol. These crystals grow to 0.125
0.125  0.375 mm in 1±2 weeks (see Fig. 1c), and freeze
beautifully after soaking in reservoir solution with increasing
amounts of ethylene glycol to a ®nal concentration of 15%.
Data to 2.5 AÊ were collected at the Cornell High Energy
Synchrotron Source (80% complete to 3.1 AÊ , 64% complete to
2.5 AÊ , Rmerge = 7.7%; see Fig. 2b). The crystals are orthor-
hombic and the data were processed in the space group P222
with a unit cell of a = 108, b = 150, c = 168 AÊ ,  =  =  = 90. If
a tetramer comprises the asymmetric unit (V = 680 400 AÊ 3),
the Vm value is 3.09 AÊ
3 Daÿ1 and the solvent content is 60%
(Matthews, 1968). Pseudo-precession images indicated the
possibility of systematic absences of 0k0 = 2n and 00l = 2n but
the h00 information was unfortunately missing in the
synchrotron data. A second data set collected on a conven-
tional X-ray source was 100% complete but only diffracted to
3.2 AÊ and with an Rmerge of 10.4%. This data was useful in
de®ning the space group as P212121 using pseudo-precession
pictures (Furey & Swaminthan, 1998).
A self-rotation function was calculated for the B crystal
form with data between 8.0 and 4.0 AÊ using the program
package X-PLOR (BruÈ nger, 1992). Only peaks which aligned
with space-group elements were observed. Therefore, it may
be inferred that the twofold axes of the tetramer lie parallel to
the twofold screw axes of the space group.
Molecular-replacement calculations of the B crystal data
using the recent class II aldehyde dehydrogenase structure
(Steinmetz et al., 1997) as a search model are currently under
way, and heavy-atom derivatives are being scanned.
The authors gratefully acknowledge support for this work
from the National Institutes of Health grants AG13566 (to
Fig. 2. (a) Diffraction pattern of type A crystal; limit of the resolution of
the image is 6 AÊ . (b) Diffraction pattern of type B crystal; limit of
the resolution of the image is 2.5 AÊ .
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